BofA lowered the firm's price target on Carlyle to $43 from $48 and keeps an Underperform rating on the shares after a management fee miss. Carlyle's growth rate is still lagging peers, the analyst tells investors. Following recent results, the firm lowered its 2026, 2027 and 2028 EPS estimates, due mainly to lower base management fees and realized principal investment income.
